(Q73520258)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10706563%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

title

Mutations of the core promoter and response to interferon treatment in chronic replicative hepatitis B (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10706563%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference

Erhardt A

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10706563%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Reineke U

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10706563%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Blondin D

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10706563%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Gerlich WH

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10706563%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Adams O

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10706563%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Heintges T

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10706563%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Niederau C

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10706563%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Häussinger D

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10706563%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

language of work or name

English

0 references

publication date

1 March 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10706563%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10706563%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

volume

31

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10706563%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10706563%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

page(s)

716-725

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10706563%20AND%20SRC:MED&resulttype=core&format=json

Global programme for control of hepatitis B infection

4 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310323

7 January 2021

Long-term follow-up of HBeAg-positive patients treated with interferon alfa for chronic hepatitis B

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310323

7 January 2021

A randomized, controlled trial of interferon alfa-2b alone and after prednisone withdrawal for the treatment of chronic hepatitis B. The Hepatitis Interventional Therapy Group

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310323

7 January 2021

Treatment of hepatitis B virus infection with interferon. Factors predicting response to interferon

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310323

7 January 2021

Natural course and response to interferon of chronic hepatitis B accompanied by antibody to hepatitis B e antigen

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310323

7 January 2021

Anti-HBe-positive chronic hepatitis B with HBV-DNA in the serum response to a 6-month course of lymphoblastoid interferon.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310323

7 January 2021

Hepatitis B virus unable to secrete e antigen and response to interferon in chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310323

7 January 2021

Interferon-alpha 2a for chronic hepatitis B with e antigen or antibody:comparable antiviral effects on wild-type virus and precore mutant

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310323

7 January 2021

A randomized controlled trial of lymphoblastoid interferon-alpha in patients with chronic hepatitis B lacking HBeAg

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310323

7 January 2021

A randomized, controlled trial of a 24-month course of interferon alfa 2b in patients with chronic hepatitis B who had hepatitis B virus DNA without hepatitis B e antigen in serum

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310323

7 January 2021

Efficacy of prolonged interferon-alpha treatment in chronic hepatitis B patients with HBeAb: comparison between 6 and 12 months of therapy

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310323

7 January 2021

The role of pre-core hepatitis B virus mutants on the long-term outcome of chronic hepatitis B virus hepatitis. A longitudinal study

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310323

7 January 2021

Mutations in the precore region of hepatitis B virus DNA in patients with fulminant and severe hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310323

7 January 2021

Hepatitis B virus precore mutation and fulminant hepatitis in the United States. A polymerase chain reaction-based assay for the detection of specific mutation

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310323

7 January 2021

Outcome of liver disease and response to interferon treatment are not influenced by hepatitis B virus core gene variability in children with chronic type B hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310323

7 January 2021

Core variability does not affect response to interferon alpha in HBeAg negative chronic hepatitis B

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310323

7 January 2021

Hepatitis B virus carriers without precore mutations in hepatitis B e antigen-negative stage show more severe liver damage

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310323

7 January 2021

Replication capacities of natural and artificial precore stop codon mutants of hepatitis B virus: relevance of pregenome encapsidation signal

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310323

7 January 2021

Naturally occurring hepatitis B virus mutants with deletions in the core promoter region

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310323

7 January 2021

Hepatitis B virus core promoter sequence analysis in fulminant and chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310323

7 January 2021

The precore/core promoter mutant (T1762A1764) of hepatitis B virus: clinical significance and an easy method for detection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310323

7 January 2021

What technique should be used for routine detection and quantification of HBV DNA in clinical samples?

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310323

7 January 2021

Quantitative assay of PCR-amplified hepatitis B virus DNA using a peroxidase-labelled DNA probe and enhanced chemiluminescence.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310323

7 January 2021

The hepatitis B virus X gene: analysis of functional domain variation and gene phylogeny using multiple sequences

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310323

7 January 2021

Effects of a frequent double-nucleotide basal core promoter mutation and its putative single-nucleotide precursor mutations on hepatitis B virus gene expression and replication

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310323

7 January 2021

Wild-type levels of pregenomic RNA and replication but reduced pre-C RNA and e-antigen synthesis of hepatitis B virus with C(1653) --> T, A(1762) --> T and G(1764) --> A mutations in the core promoter

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310323

7 January 2021

High prevalence of 1762(T) 1764(A) mutations in the basic core promoter of hepatitis B virus isolated from black Africans with hepatocellular carcinoma compared with asymptomatic carriers.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310323

7 January 2021

Reduced antigen production by hepatitis B virus harbouring nucleotide deletions in the overlapping X gene and precore-core promoter

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310323

7 January 2021

Reduced precore transcription and enhanced core-pregenome transcription of hepatitis B virus DNA after replacement of the precore-core promoter with sequences associated with e antigen-seronegative persistent infections.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310323

7 January 2021

Effects of a naturally occurring mutation in the hepatitis B virus basal core promoter on precore gene expression and viral replication

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310323

7 January 2021

The hepatitis B virus (HBV) precore protein inhibits HBV replication in transgenic mice

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310323

7 January 2021

Precore-mediated inhibition of hepatitis B virus progeny DNA synthesis.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310323

7 January 2021

Hepatitis B virus X gene 1751 to 1764 mutations: implications for HBeAg status and disease

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310323

7 January 2021

Members of the nuclear receptor superfamily regulate transcription from the hepatitis B virus nucleocapsid promoter.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310323

7 January 2021

The orphan receptors COUP-TF and HNF-4 serve as accessory factors required for induction of phosphoenolpyruvate carboxykinase gene transcription by glucocorticoids

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310323

7 January 2021

Seven-up, the Drosophila homolog of the COUP-TF orphan receptors, controls cell proliferation in the insect kidney

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310323

7 January 2021

COUP-TF gene: a structure unique for the steroid/thyroid receptor superfamily

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310323

7 January 2021

Mutations of the X region of hepatitis B virus and their clinical implications

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310323

7 January 2021

Identifiers

DOI

10.1002/HEP.510310323

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10706563%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference